FrancophonIA/ELRC3.0 huggingface dataset:
English: Accidental injection of liquid paraffin may cause severe pain and swelling, particularly if injected into a joint or finger - this could result in the loss of the finger if prompt medical attention is not given.
Maltese: Injezzjoni aċċidentali tal-paraffin likwidu tista' tikkawża wġigħ sever u nefħa, partikolarment jekk jiġi injettat f'ġog jew f'saba - dan jista' jwassal għat-telf tas-saba jekk ma tingħatax attenzjoni medika minnufih.
English: How is Aftovaxpur DOE used?
Maltese: Kif jintuża Aftovaxpur DOE?
English: When animals are vaccinated at 2 weeks of age, revaccination is recommended at 8 to 10 weeks.
Maltese: Meta l-annimali jitlaqqmu ta' ġimagħtejn, it-tilqim mill-ġdid huwa rakkomandat li jsir meta jkollhom bejn 8 u 10 ġimgħat'.
English: The withdrawal period for meat and milk from cattle and sheep and for meat from pigs treated with Aftovaxpur DOE is ‘zero' days which means that there is no mandatory waiting time.
Maltese: Dan kien meqjus aċċettabbli, minħabba d-data mil-laboratorju u fiddawl tal-fatt li t-tilqim kontra l-marda tal-ilsien u d-dwiefer attwalment huwa pprojbit fl-UE taħt kontrolli legali fuq il-marda tal-ilsien u d-dwiefer.
English: Aftovaxpur DOE contains up to three strains of inactivated (killed) foot-and-mouth disease virus.
Maltese: Aftovaxpur DOE fih sa tliet razez tal-virus inattivat (maqtul) tal-marda tal-ilsien u ddwiefer.
English: Vaccines work by ‘teaching' the immune system (the body's natural defences) how to defend itself against a disease.
Maltese: Il-vaċċini jaħdmu billi "jgħallmu" lis-sistema immunitarja (id-difiżi naturali tal-ġisem) kif tiddefendi ruħha kontra marda.
English: How does Aftovaxpur DOE work?
Maltese: Kif jaħdem Aftovaxpur DOE?
English: Why is Aftovaxpur DOE authorised in the EU?
Maltese: Għaliex Aftovaxpur DOE huwa awtorizzat fl-UE?
English: 1 pre-filled syringe + 1 needle
Maltese: Daqs talpakkett siringa 1 mimlija minn qabel + labra 1
English: The full EPAR for Cystadrops can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Maltese: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: The summary of the opinion of the Committee for Orphan Medicinal Products for Cystadrops can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/Rare disease designation.
Maltese: ema.europa.eu/Find medicine/Human medicines/Rare disease designation.
English: Cystadrops was shown to be more effective than the comparator at decreasing corneal cystine crystals after 3 months of treatment: in patients using Cystadrops the IVCM score decreased by 4.6 points compared with a decrease of 0.5 points in patients using the comparator.
Maltese: Cystadrops wera li kien aktar effettiv mill-komparatur fit-tnaqqis tal-kristalli taċ-ċistina fil-kornea wara tliet xhur ta' kura: fil-pazjenti li kienu qed jużaw Cystadrops, il-punteġġ IVCM naqas b'4.6 punti meta mqabbel mat-tnaqqis ta' 0.5 punti fil-pazjenti li użaw il-komparatur.
English: These effects are usually mild or moderate and do not last.
Maltese: Dawn l-effetti normalment huma ħfief jew moderati u ma jdumux ħafna.
English: The score ranges from 0 to 28, with 0 corresponding to no crystals.
Maltese: Il-punteġġ jvarja minn 0 sa 28, b'0 li jikkorrispondi għall-ebda kristall.
English: This is a summary of the European public assessment report (EPAR) for Cystadrops.
Maltese: Dan huwa sommarju tar-rapport pubbliku Ewropew ta' valutazzjoni (EPAR) għal Cystadrops.
English: EPAR summary for the public
Maltese: Sommarju tal-EPAR għall-pubbliku merkaptamina
English: Cystadrops mercaptamine
Maltese: Informazzjoni oħra dwar Cystadrops
English: Cystadrops contains the active substance mercaptamine (also known as cysteamine).
Maltese: Cystadrops fih is-sustanza attiva, il-merkaptamina (magħrufa wkoll bħala ċisteamina).
English: Because the number of patients with cystinosis is low, the disease is considered ‘rare', and Cystadrops was designated an ‘orphan medicine' (a medicine used in rare diseases) on 7 November 2008.
Maltese: Minħabba li l-għadd ta' pazjenti b'ċistinożi huwa baxx, il-marda hija kkunsidrata "rari" u fis-7 ta' Novembru 2008, Cystadrops ġie kklassifikat bħala "mediċina orfni" (mediċina użata f'mard rari).
English: Why is Cystadrops approved?
Maltese: Għaliex ġie approvat Cystadrops?
English: The most common side effects with Cystadrops (which may affect more than 1 in 10 people) are related to the eye and include pain, itching and irritation in the eye, increased lacrimation (watering eyes), blurred vision and ocular hyperaemia (red eye).
Maltese: L-effetti sekondarji l-aktar komuni b'Cystadrops (li jistgħu jaffetwaw aktar minn persuna 1 minn kull 10) huma relatati mal-għajnejn u jinkludu wġigħ, ħakk u irritazzjoni fl-għajn, żieda fit-tidmigħ (għajnejn li jdemmgħu), vista mċajpra u iperimija okulari (għajnejn ħomor).
English: The active substance in Cystadrops, mercaptamine, reacts with cystine to dissolve it and to form substances that can be removed from the cells.
Maltese: Is-sustanza attiva f'Cystadrops, il-merkaptamina, tirreaġixxi maċ-ċistina sabiex iddewwibha u sabiex tifforma sustanzi li jistgħu jitneħħew miċ-ċelloli.
English: Cystadrops has been compared with another less concentrated mercaptamine eye drop solution in one main study involving 32 patients from 2 years of age with cystinosis.
Maltese: Cystadrops tqabbel ma' soluzzjoni tat-taqtir tal-għajnejn bil-merkaptamina oħra li hija inqas ikkonċentrata fi studju ewlieni wieħed li fih ħadu sehem 32 pazjent minn sentejn 'il fuq b'ċistinożi.
English: Cystinosis is an inherited disease where a natural substance called cystine builds up in the body forming damaging crystals, particularly in the kidneys and cornea (the transparent layer in front of the eye).
Maltese: Ċistinożi hija marda li tintiret fejn sustanza naturali msejħa ċistina tikber fil-ġisem u tifforma kristalli li jagħmlu l-ħsara, b'mod partikolari fil-kliewi u fil-kornea (is-saff trasparenti quddiem l-għajn).
English: What are the risks associated with Cystadrops?
Maltese: X'inhuma r-riskji assoċjati ma' Cystadrops?
English: The medicine also improved other symptoms of cystinosis such as photophobia.
Maltese: Il-mediċina tejbet ukoll is-sintomi ta' ċistinożi bħall-fobija mir-ritratti (photophobia).
English: Cystadrops can only be obtained with a prescription and treatment should be started under the supervision of a doctor experienced in the management of cystinosis.
Maltese: Dan mhux maħsub biex jipprovdi konsultazzjoni prattika dwar l-użu ta' Cystadrops.
English: Cystadrops is used to reduce the build-up of cystine crystals in the cornea.
Maltese: Cystadrops jintuża biex inaqqas l-akkumulazzjoni tal-kristalli taċ-ċistina fil-kornea.
English: In addition, Cystadrops has been shown in a study to be effective at decreasing corneal cystine crystals.
Maltese: Barra minn hekk, Cystadrops wera fi studju li kien effikaċi fit-tnaqqis tal-kristalli taċ-ċistina fil-kornea.
English: For the full list of all side effects and restrictions with Cystadrops, see the package leaflet.
Maltese: Għal-lista sħiħa tal-effetti sekondarji u r-restrizzjonijiet kollha b'Cystadrops, ara l-fuljett ta' tagħrif.
English: How is Cystadrops used?
Maltese: Kif jaħdem Cystadrops?
English: The recommended dose is 1 drop in each eye 4 times a day during waking hours.
Maltese: Id-doża rakkomandata hija taqtira f'kull għajn 4 darbiet f'ġurnata meta l-persuna tkun imqajma.
English: EMA/357446/2015 EMEA/H/C/001195
Maltese: EMEA/H/C/001195
English: It is available as tablets (50 and 150 mg).
Maltese: Jiġi bħala pilloli (50 u 150 mg).
English: The full EPAR for Ibandronic Acid Teva can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Maltese: ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: Ibandronic Acid Teva EMA/357446/2015
Maltese: EMA/357446/2015
English: The European Commission granted a marketing authorisation valid throughout the EU for Ibandronic Acid Teva on 17 September 2010.
Maltese: Il-Kummissjoni Ewropea tat awtorizzazzjoni għat-tqegħid fis-suq valida fl-UE kollha għal Ibandronic Acid Teva fis-17 ta' Settembru 2010.
English: The active substance in Ibandronic Acid Teva, ibandronic acid, is a bisphosphonate.
Maltese: Is-sustanza attiva f'Ibandronic Acid Teva, l-aċidu ibandroniku, huwa bisfosfonat.
English: Ibandronic Acid Teva ibandronic acid
Maltese: Ibandronic Acid Teva aċidu ibandroniku
English: Ibandronic Acid Teva 50 mg is used to prevent ‘skeletal events' (fractures [broken bones] or bone complications requiring treatment) in patients with breast cancer and bone metastases (when the cancer has spread to the bone).
Maltese: Ibandronic Acid Teva 50 mg jintuża biex jipprevjeni ‘episodji skeletali' (ksur [ta' għadam] jew kumplikazzjonijiet tal-għadam li jeħtieġu kura) f'pazjenti b'kanċer tas-sider u b'metastasi fl-għadam (meta l-kanċer ikun infirex għall-għadam).
English: Ibandronic Acid Teva is a medicine that contains the active substance ibandronic acid.
Maltese: Ibandronic Acid Teva huwa mediċina li fiha s-sustanza attiva aċidu ibandroniku.
English: The CHMP concluded that, in accordance with EU requirements, Ibandronic Acid Teva has been shown to have comparable quality and to be bioequivalent to Bondronat and Bonviva.
Maltese: Is-CHMP kkonkluda li, f'konformità mar-rekwiżiti tal-UE, Ibandronic Acid Teva wera li għandu kwalità komparabbli ma' Bondronat u Bonviva u huwa bijoekwivalenti għalihom.
English: Other information about Ibandronic Acid Teva:
Maltese: Aktar informazzjoni dwar Ibandronic Acid Teva:
English: This means that Ibandronic Acid Teva is similar to a ‘reference medicine' already authorised in the European Union (EU).
Maltese: Ibandronic Acid Teva huwa ‘mediċina ġenerika' Dan ifisser li Ibandronic Acid Teva huwa simili għall‘mediċina ta' referenza' diġà awtorizzata fl-Unjoni Ewropea (UE).
English: This is a summary of the European public assessment report (EPAR) for Ibandronic Acid Teva.
Maltese: Dan huwa sommarju tar-rapport pubbliku Ewropew ta' valutazzjoni (EPAR) għal Ibandronic acid Teva.
English: For the prevention of skeletal events, one 50-mg tablet is taken once a day.
Maltese: Għall-prevenzjoni ta' episodji skeletali, tittieħed pillola waħda ta' 50-mg darba kuljum.
English: The reference medicines for Ibandronic Acid Teva are Bondronat and Bonviva.
Maltese: Il-mediċini ta' referenza għal Ibandronic Acid Teva huma Bondranat u Bonviva.
English: Ibandronic Acid Teva 150 mg is used to treat osteoporosis (a disease that makes bones fragile) in women who have been through the menopause and are at risk of developing bone fractures.
Maltese: Ibandronic Acid Teva 150 mg jintuża fil-kura tal-osteoporożi (marda li ddgħajjef l-għadam) f'nisa li jkunu għaddew mill-menopawża u li hemm ir-riskju li jiżviluppaw ksur fl-għadam.
English: Because Ibandronic Acid Teva is a generic medicine, studies in people have been limited to tests to determine that it is bioequivalent to the reference medicines.
Maltese: Peress li Ibandronic Acid Teva huwa mediċina ġenerika, l-istudji f'pazjenti ġew limitati għal testitjiet biex jiddeterminaw il-bijoekwivalenza tiegħu mal-mediċini ta' referenza.
English: The tablets must always be taken after the patient has fasted overnight for at least six hours and at least 30 minutes before the first food or drink of the day.
Maltese: Il-pilloli jridu jittieħdu dejjem wara li l-pazjent ikun ilu sajjem mal-lejl għal mill-anqas sitt sigħat u mill-anqas 30 minuta qabel l-ewwel ikla jew xarba tal-jum.
English: What is Ibandronic Acid Teva?
Maltese: X'hinu Ibandronic Acid Teva?
English: Because Ibandronic Acid Teva is a generic medicine and is bioequivalent to the reference medicines, its benefits and risks are taken as being the same as the reference medicines's.
Maltese: Peress li Ibandronic Acid Teva huwa mediċina ġenerika u huwa bijoekwivalenti għall-mediċini ta' referenza, il-benefiċċji u r-riskji tiegħu jitqiesu li huma l-istess bħal dawk tal-mediċini ta' referenza.
English: For treating osteoporosis, one 150-mg tablet is taken once a month.
Maltese: Għall-kura tal-osteoporożi, tittieħed pillola waħda ta' 150-mg darba fix-xahar.
English: The reduction of bone loss helps to make bones less likely to break, which is useful in preventing fractures in cancer patients with bone metastases and in women with osteoporosis.
Maltese: It-tnaqqis ta' telf ta' għadam jgħin biex ikun hemm inqas probabbiltà li l-għadam jinkiser, u dan huwa utli għall-prevenzjoni ta' ksur f'pazjenti bil-kanċer tal-metastasi flgħadam u f'nisa b'osteoporożi.
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 10 November 2017
Maltese: DATA TAL-EWWEL AWTORIZZAZZJONI/TIĠDID TAL-AWTORIZZAZZJONI Data tal-ewwel awtorizzazzjoni: 10 Novembru, 2017
English: The active substance is ritonavir.
Maltese: - Is-sustanza attiva hi ritonavir.
English: Immunosuppressants Cyclosporine, tacrolimus, everolimus
Maltese: Mediċini Immuno-Suppressanti Cyclosporine, tacrolimus, everolimus
English: Alpha1-Adrenoreceptor antagonist Alfuzosin
Maltese: Antagonist Alpha1-Adrenoreceptor Alfuzosin
English: β2-agonist (long acting) Salmeterol
Maltese: β2-agonist (iħalli effett fit-tul) Salmeterol
English: Hypromellose Titanium dioxide (E171) Macrogols
Maltese: Titanium dioxide (E171)
English: 14-OH clarithromycin metabolite
Maltese: Metabolat 14-OH clarithromycin
English: ↑ 64% ↑ 5 fold
Maltese: ↑ 64% ↑ b'5 darbiet
English: Antiasthmatic Theophylline1
Maltese: Mediċini kontra l-Ażżma Theophylline1
English: Ergot derivatives Dihydroergotamine, ergonovine, ergotamine, methylergonovine
Maltese: Derivattivi tal-Ergotina Dihydroergotamine, ergonovine, ergotamine, methylergonovine
English: 10 days
Maltese: 10 ijiem
English: Stevens Johnson syndrome, toxic epidermal necrolysis (TEN)
Maltese: Sindromu Stevens Johnson, Nekroliżi tossika talepidermide (TEN)
English: Norbuprenorphine Glucuronide metabolites
Maltese: Norbuprenorphine Metabolati Glucuronide
English: Amphetamine derivatives Amphetamine
Maltese: Derivattivi tal-Amfetamina Amfetamina
English: Generics [UK] Limited, Station Close, Potters Bar, Hertfordshire, EN6 1TL, United Kingdom
Maltese: Generics [UK] Limited, Station Close, Potters Bar, Hertfordshire, EN6 1TL, ir-Renju Unit
English: (μg•h/ml) t1/2 (h)
Maltese: Cl/F (L/h)
English: Norpethidine metabolite
Maltese: Metabolat Norpethidine
English: Phosphodiesterase (PDE5) inhibitors
Maltese: Impedituri Phosphodiesterase (PDE5) Avanafil
English: 175 mg (2.2 ml) twice daily 200mg in the morning and 200mg in the evening 350 mg (4.4 ml) twice daily 400mg in the morning and 300mg in the evening 437.5 mg (5.5 ml) twice daily 500mg in the morning and 400mg in the evening 525 mg (6.6 ml) twice daily 500mg in the morning and 500mg in the evening
Maltese: 175 mg (2.2 mL) darbtejn kuljum 200mg filgħodu u 200mg filgħaxija 350 mg (4.4 mL) darbtejn kuljum 400 mg filgħodu u 300 mg filgħaxija 437.5 mg (5.5 mL) darbtejn kuljum 500 mg filgħodu u 400 mg filgħaxija 525 mg (6.6 mL) darbtejn kuljum 500 mg filgħodu u 500 mg filgħaxija
English: Mylan S.A.S., 117 Allée des Parcs, Saint-Priest, 69800, France
Maltese: Mylan S.A.S., 117 Allée des Parcs, Saint-Priest, 69800, Franza
English: Digoxin (heart medicine).
Maltese: - Digoxin (mediċina għall-qalb).
English: 117 Allée des Parcs, Saint-Priest, 69800, France
Maltese: 117 Allée des Parcs, Saint-Priest, 69800, Franza
English: Reduction in the antiretroviral activity of ritonavir is primarily associated with the protease mutations V82A/F/T/S and I84V.
Maltese: Nuqqas fl-attività antiretrovirali ta' ritonavir huwa primarjament assoċjat mal-mutazzjoni tal-preotejażi V82A/F/T/S u I84V.
English: Mylan S.A.S Tel: + 33 4 37 25 75 00
Maltese: Mylan S.A.S Tél : + 33 4 37 25 75 00
English: ↑ 86% ND
Maltese: ↑ 86% MD
English: Antidepressants Amitriptyline, fluoxetine, imipramine, nortriptyline, paroxetine, sertraline
Maltese: Mediċini għal kontra d-Dipressjoni Amitriptyline, fluoxetine, imipramine, nortriptyline, paroxetine, sertraline
English: Hydroxypropylcellulose Talc
Maltese: Hydroxypropyl cellulose
English: 25-O-desacetyl rifabutin metabolite
Maltese: Metabolat 25-O-desacetyl rifabutin
English: The AUC of the metabolite prednisolone increased by 37 and 28% after 4 and 14 days ritonavir, respectively.
Maltese: L-AUC tal-metabolit prednisolone żdied b'37 u 28% wara 4 u 14-il ġurnata b'ritonavir, rispettivament.
English: The tablet coating is composed of: hypromellose, titanium dioxide (E171), macrogols, hydroxypropylcellulose, talc, iron oxide yellow (E172), colloidal anhydrous silica, polysorbate
Maltese: - Ir-rita ta' barra tal-pillola hija magħmula minn: hypromellose, titanium dioxide (E171), macrogols, hydroxypropylcellulose, talc, iron oxide yellow (E172), colloidal anhydrous silica, polysorbate 80.
English: Anti-infectives Fusidic acid
Maltese: Mediċini Anti-bijotiċi Fusidic Acid
English: Cmax (μg/ml) Ctrough (μg/ml) 0.08 ± 0.04 0.22
Maltese: 39 0.89 Ctrough (µg/mL) 0.08 ±0.04 0.22
English: Accumulation of other mutations in the protease gene (including at positions 20, 33, 36, 46, 54, 71, and 90) can also contribute to ritonavir resistance.
Maltese: L-akkumulazzjoni ta' mutazzjonijiet oħra fil-ġene tal-protejazi (inkluż f'pożizzjonijiet 20, 33, 36, 46, 54, 71, u 90) tista' tikkontribwixxi ukoll għar-resistenza għal ritonavir.
English: Increased plasma concentrations of norpethidine, piroxicam and propoxyphene.
Maltese: Żieda fil-konċentrazzjoni fil-plażma ta' norpethidine, piroxicam u propoxyphene.
English: Microsomal triglyceride transfer protein (MTTP) inhibitor
Maltese: Impeditur tal-proteina li tittrasferixxi ltrigliċerida microsomali (MTTP - microsomal triglyceride transfer protein)
English: 800/160, single dose
Maltese: 800/160, doża waħda
English: The maximum mean (95% upper confidence bound) difference in QTcF from placebo was 5.5 (7.6) for 400 mg twice daily ritonavir.
Maltese: Id-differenza medja massima (95% upper confidence bound) filQTcF mill-plaċebo kienet ta' 5.5 (7.6) fejn ingħatat doża ta' 400 mg ritonavir darbtejn kuljum.
English: Sildenafil or tadalafil for impotence (erectile dysfunction).
Maltese: - Sildenafil jew tadalafil għall-impotenza (disfunsjoni erettili).
English: Component of a multipack can't be sold separately.
Maltese: Komponent ta' pakkett multiplu ma jistax jinbiegħ separatament.
English: Clinical pharmacodynamic data
Maltese: Informazzjoni klinika farmakodinamika
English: MARKETING AUTHORISATION NUMBER(S) EU/1/17/1242/001 30 film-coated tablets EU/1/17/1242/002 90 film-coated tablets EU/1/17/1242/003 100 film-coated tablets
Maltese: TAL-AWTORIZZAZZJONI GĦAT-TQEGĦID FIS-SUQ EU/1/17/1242/001 30 pillola miksija b'rita EU/1/17/1242/002 90 pillola miksija b'rita EU/1/17/1242/003 100 pillola miksija b'rita
English: HCV protease inhibitor Simeprevir
Maltese: Impeditur tal-protejaż ta' HCV Simeprevir
English: Renal failure, renal impairment, elevated creatinine, hypophosphataemia and proximal tubulopathy (including Fanconi syndrome) have been reported with the use of tenofovir disoproxil fumarate (DF) in clinical practice (see section 4.8).
Maltese: Insuffiċjenza renali, indeboliment renali, krejatinina għolja, ipofosfatimja u tubulopatija prossimali (inkluż is-sindromu ta' Fanconi) kienu rrappurtati bl-użu ta' tenofovir disoproxil fumarate (DF) fl-użu kliniku (ara sezzjoni 4.8).
English: Anticancer agents Afatinib
Maltese: Aġenti kontra l-kanċer Afatinib
English: ↑ 38-fold ↑ 16-fold
Maltese: ↑ bi 38 darba ↑ b'16-il darba
English: Anorexia, flatulence, mouth ulcer, gastrointestinal haemorrhage, gastroesophageal reflux disease, pancreatitis
Maltese: Anoressija, gass fl-istonku, ulċera fil-ħalq, emorraġija gastrointestinali, mard tar-rifluss gastroesofagali, pankreatite
English: In intent to treat analyses, 50% and 57% of patients in the 350 and 450 mg/m2 dose groups, respectively, achieved reduction in plasma HIV-1 RNA to ≤ 400 copies/ml at Week 48.
Maltese: Bl-intenzjoni li jiġu ttrattati analisi, 50% u 57% tal-pazjenti fil-gruppi dożati 350 and 450 mg/m² rispettivament, kellhom nuqqas fl-HIV-1 RNA fil-plażma għal ≤400 kopji/mL f'Ġimgħa 48.
English: Patients with impaired renal function
Maltese: Pazjenti b'indeboliment funzjonali renali
English: Food slightly decreases the bioavailability of the ritonavir tablet.
Maltese: L-ikel inaqqas kemm mhux xejn il-biodisponibiltà tal-pillola ritonavir.
English: Administration of a single 100 mg dose of ritonavir tablet with a moderate fat meal (857 kcal, 31% calories from fat) or a high fat meal (907 kcal, 52% calories from fat) was associated with a mean decrease of 20-23% in ritonavir AUC and Cmax.
Maltese: It-teħid ta' doża waħda ta' 100 mg ta' pillola ritonavir ma' ikla li fiha kontenut ta' xaħam moderat (857 kcal, 31% tal-kaloriji mix-xaħam) jew ma' ikla li fiha kontenut għoli ta' xaħam (907 kcal, 52% tal-kaloriji mix-xaħam) ġie assoċjat ma' tnaqqis medju ta' bejn 20 - 23% fl-AUC u Cmax ta' ritonavir.
English: INFORMATION IN BRAILLE Ritonavir Mylan
Maltese: INFORMAZZJONI BIL-BRAILLE Ritonavir Mylan
English: Ritonavir Mylan film-coated tablets are available in plastic bottles with screw caps containing 30, 90 or 100 tablets and in multipacks of 90 tablets comprising 3 bottles, each containing 30 tablets.
Maltese: Il-pilloli miksija b'rita Ritonavir Mylan huma disponibbli fi fliexken tal-plastik b'tappijiet bil-kamin li jkun fihom 30, 90 jew 100 pillola u f'pakketti multipli ta' 90 pillola li jinkludu 3 fliexken, li kull wieħed ikun fih 30 pillola.
English: Effect on Coadministered Medicinal Products AUC
Maltese: Effetti fuq prodotti mediċinali oħra
English: Pack sizes: 30, 90, 100 and multipack containing 90 (3 bottles of 30) film-coated tablets.
Maltese: Daqsijiet tal-pakketti: 30, 90, 100 u pakkett multiplu li jkun fih 90 (3 fliexken ta' 30) pillola miksija b'rita.
English: Ritonavir adversely interacts with oral contraceptives (OCs).
Maltese: Ritonavir għandu effetti ħżiena fuq kontraċettivi orali (OCs).
English: McDermott Laboratories Limited trading as Gerard Laboratories trading as Mylan Dublin, Unit 35/36 Baldoyle Industrial Estate,
Maltese: McDermott Laboratories Limited li tikkummerċjalizza bħala Gerard Laboratories li tikkummerċjalizza bħala Mylan Dublin,
English: ND: Not determined
Maltese: MD: Mhux determinat
English: The mean average change from baseline over 48 weeks for HIV RNA levels was -0.88 log10 in the ritonavir group versus -0.66 log10 in the ritonavir + zidovudine group versus -0.42 log10 in the zidovudine group.
Maltese: 88 log10 fil-grupp ta' ritonavir kontra −0.66 log10 fil-grupp ta' ritonavir + zidovudine kontra −0.42 log10 fil-grupp ta' zidovudine.
English: Increased amylase, decreased free and total thyroxin
Maltese: Żieda fl-amylase, tnaqqis fit-thyroxin ħieles u totali
English: The mean average change from baseline over 16 weeks for HIV RNA levels was -0.79 log10 (maximum mean decrease: 1.29 log10) in the ritonavir group versus -0.01 log10 in the control group.
Maltese: 79 log10 (medja ta' tnaqqis massimu: 1.29 log10) fil-grupp ta' ritonavir kontra −0.01 log10 fil-grupp ta' kontroll.
English: HMG-CoA reductase inhibitors
Maltese: Impedituri HMG-CoA reductase
English: • diarrhoea (may be severe)
Maltese: • dijarea (tista' tkun severa)
English: Increased plasma concentrations of fusidic acid and ritonavir.
Maltese: Żieda fil-konċentrazzjoni fil-plażma tal-fusidic acid u ritonavir.
English: The apparent volume of distribution (VB/F) of ritonavir is approximately 20 - 40 l after a single 600 mg dose.
Maltese: Il-volum apparenti ta' distribuzzjoni (VB/F) ta' ritonavir hu bejn wieħed u ieħor 20 - 40 L wara doża waħda ta' 600 mg.
English: Increased urination, renal impairment (e.g. oliguria, elevated creatinine)
Maltese: Żieda fl-awrina, indeboliment renali (e.ż. oligurja, żieda fil-kreatinina
English: Antipsychotics/ Neuroleptics
Maltese: Mediċini Anti-Psikotiċi/ Newrolettiċi
English: The other tablet ingredients are: copovidone, sorbitan laurate, colloidal anhydrous silica, sodium chloride, sodium stearyl fumarate see section 2 ‘Ritonavir Mylan contains sodium'.
Maltese: Is-sustanzi l-oħra tal-pillola huma: copovidone, sorbitan laurate, colloidal anhydrous silica, sodium chloride, sodium stearyl fumarate (ara sezzjoni 2 ‘Ritonavir Mylan fih is-sodium').